Root Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Sell
1,649
-1,304
-44% -$1.32M 0.07% 77
2025
Q4
$3.17M Buy
2,953
+137
+5% +$131K 0.16% 43
2025
Q3
$2.15M Sell
2,816
-203
-7% -$151K 0.13% 48
2025
Q2
$2.35M Buy
3,019
+631
+26% +$490K 0.23% 41
2025
Q1
$1.97M Sell
2,388
-37
-2% -$30.8K 0.21% 36
2024
Q4
$1.87M Buy
2,425
+233
+11% +$193K 0.23% 33
2024
Q3
$1.94M Buy
2,192
+1,730
+374% +$1.56M 0.31% 28
2024
Q2
$418K Buy
462
+40
+9% +$32K 0.1% 76
2024
Q1
$329K Buy
+422
New +$300K 0.1% 72

Other funds holding LLY

Root Financial Partners's LLY Position: Q1 2026 in Review

Root Financial Partners reduced its Eli Lilly (LLY) stake by 44% in Q1 2026, selling an estimated $1.32M and leaving 1,649 shares worth $1.52M. The position accounts for 0.07% of the portfolio, ranked #77.

Root Financial Partners first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.17M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Root Financial Partners held 1,649 shares of Eli Lilly worth $1.52M as of Q1 2026.
  • Root Financial Partners sold 1,304 Eli Lilly shares in Q1 2026, an estimated $1.32M.
  • Eli Lilly made up 0.07% of Root Financial Partners's portfolio in Q1 2026, its #77 holding.
  • Root Financial Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Root Financial Partners's Eli Lilly position peaked at $3.17M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.